The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
NCRI 2019 | Precision medicine in gastrointestinal cancers: promise and pitfalls
Russell Petty
• 5 Nov 2019
Russell Petty, BMSC, MB ChB, PhD, MRCP, University of Dundee, Dundee, UK, talks about the promise and pitfalls with precision medicine in gastrointestinal cancers. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.
